TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway

被引：0
|
作者：
Liqiang Shi [1 ]
Yajie Zhang [1 ]
Cong Yang [2 ]
Yaxin Wang [1 ]
Yichao Han [1 ]
Chuanyin Li [3 ]
Yun Yang [4 ]
Dong Dong [1 ]
Mingyuan Du [1 ]
Hecheng Li [1 ]
机构：
[1] Ruijin Hospital,Department of Thoracic Surgery
[2] Shanghai Jiao Tong University School of Medicine,Cancer Center, School of Medicine, Shanghai Tenth People’s Hospital
[3] Tongji University,Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affi
[4] Zhejiang University School of Medicine,Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Sciences, Hangzhou Institute for Advanced Study
[5] University of Chinese Academy of Sciences,undefined
来源：
Journal of Cancer Research and Clinical Oncology | / 151卷 / 4期
关键词：
TROAP; Esophageal squamous cell carcinoma; Malignant phenotype; PI3K/AKT;
D O I：
10.1007/s00432-025-06200-2
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] miR-30c-5p inhibits esophageal squamous cell carcinoma progression by repressing the PI3K/AKT signaling pathway
    Shi, Haochun
    Pan, Binyang
    Liang, Jiaqi
    Cai, Benjie
    Wu, Gujie
    Bian, Yunyi
    Shan, Guangyao
    Ren, Shencheng
    Huang, Yiwei
    Guo, Weigang
    THORACIC CANCER, 2024, 15 (30) : 2206 - 2216
  • [42] SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway
    Shi, Haoming
    Luo, Jun
    Ye, Liu
    Duan, Changzhu
    Zhang, Min
    Ran, Haoyu
    Li, Changying
    Wu, Qingchen
    Shao, Yue
    CELLULAR SIGNALLING, 2024, 114
  • [43] PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway
    Wang, Zijia
    Xiong, Haofeng
    Zuo, Yijie
    Hu, Shujun
    Zhu, Chao
    Min, Anjie
    CELL CYCLE, 2022, 21 (05) : 477 - 488
  • [44] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [45] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
    Simpson, Daniel R.
    Mell, Loren K.
    Cohen, Ezra E. W.
    ORAL ONCOLOGY, 2015, 51 (04) : 291 - 298
  • [46] Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway
    Qu, Yi
    He, Ying
    Ruan, Hanjin
    Qin, Lizheng
    Han, Zhengxue
    CANCER MEDICINE, 2023, 12 (05): : 5781 - 5797
  • [47] Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells
    Zou, Naiyi
    Zhang, Xueyuan
    Li, Shuguang
    Li, Youmei
    Zhao, Yan
    Yang, Xingxiao
    Zhu, Shuchai
    JOURNAL OF CANCER, 2021, 12 (16): : 5013 - 5024
  • [48] GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway
    Wang, Yadong
    Fang, Xiaosan
    Xie, Hao
    Wang, Xiaoming
    BIOCHEMICAL GENETICS, 2024,
  • [49] The role of PI3K/AKT pathway in cell proliferation and apoptosis in oral Squamous Cell Carcinoma
    Ribeiro-Silva, A.
    Duarte, A.
    Silveira, G.
    VIRCHOWS ARCHIV, 2016, 469 : S116 - S116
  • [50] CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway
    Shen, Fan
    Zong, Zhi-hong
    Liu, Yao
    Chen, Shuo
    Sheng, Xiu-jie
    Zhao, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
12345